INSTITUT CURIE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: Activity tracker
- First Posted Date
- 2021-08-18
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 300
- Registration Number
- NCT05011721
- Locations
- 🇫🇷
Institut Curie, Saint-Cloud, France
🇫🇷Institut Jean Godinot, Reims, France
Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE)
- Conditions
- Cancer
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 118
- Registration Number
- NCT04994730
- Locations
- 🇫🇷
Institut Curie, Paris, France
Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG
Not Applicable
Completed
- Conditions
- Lung Cancer
- Interventions
- Device: Patients treated for their lung cancer.
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 240
- Registration Number
- NCT04934865
- Locations
- 🇫🇷
Hôpital Nord-Ouest, Gleize, France
🇫🇷Chu Argenteuil, Argenteuil, France
🇫🇷Centre Hospitalier Public du Cotentin, Cherbourg, France
Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
Completed
- Conditions
- Solid Tumor, AdultChemotherapy EffectSolid Tumor, Childhood
- Interventions
- Other: Evaluation on appearance of unpleasant body odors
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 27
- Registration Number
- NCT04899505
- Locations
- 🇫🇷
Institut Curie, Paris, France
Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial
Completed
- Conditions
- Clinical TrialSupportive CareMetastatic Cancer
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 42
- Registration Number
- NCT04896099
- Locations
- 🇫🇷
Institut Curie, Paris, France
ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery
Phase 4
Completed
- Conditions
- Breast Surgery
- Interventions
- Drug: Ropivacaïne Hydrochloride by Paravertebral blockDrug: Ropivacaïne Hydrochloride by Erector Spinae block
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 292
- Registration Number
- NCT04827030
- Locations
- 🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷AP-HP Hôpital Tenon, Paris, France
🇫🇷Institut Claudius Régaud UICT, Toulouse, France
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
Not Applicable
Recruiting
- Conditions
- Advanced CancerCarcinoma, Non-Small-Cell Lung
- Interventions
- Other: Optimization of the medical decisionOther: Usual care
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 364
- Registration Number
- NCT04823377
- Locations
- 🇫🇷
CHU Amiens - Hôpital Sud, Amiens, France
🇫🇷CH Abbeville, Abbeville, France
🇫🇷CH du Pays d'Aix, Aix-en-Provence, France
Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia
Not Applicable
Active, not recruiting
- Conditions
- Implanted Venous Access Device
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 127
- Registration Number
- NCT04804735
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
🇫🇷Institut Curie, Saint-cloud, France
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
Not Applicable
Recruiting
- Conditions
- Metastatic Lung Cancer
- Interventions
- Biological: assessment of the predictive value of ctDNA level of the prominent mutant allele variation between baseline and week 6, on response to treatment according to RECIST 1.1 criteria.
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 300
- Registration Number
- NCT04790682
- Locations
- 🇫🇷
Hopital Ambroise Pare, Boulogne Billancourt, France
🇫🇷Institut Curie, Saint-cloud, France
Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer
Completed
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: HFRDIS questionnaire completion
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 290
- Registration Number
- NCT04775043
- Locations
- 🇫🇷
Institut Curie, Saint-Cloud, France
© Copyright 2025. All Rights Reserved by MedPath